TYPHIBEV®



Product overview

Type: 
Typhoid (Conjugate)
Commercial Name: 
TYPHIBEV®
Manufacturer: 
Biological E. Limited
Country: 
India
Responsible NRA: 
Central Drugs Standard Control Organization
Country: 
India
Bulk Supplier: 
Not applicable

Prequalification

Prequalification Status: 
Current
Effective Date: 
04/12/2020

Product description

Pharmaceutical Form: 
Liquid: ready to use
Presentation: 
Vial
Number of Doses: 
1
Diluent: 
Not Applicable
Route of Administration: 
Intramuscular

Shelf Life:

24 months
at storage temperature: 
2-8°C
Vaccine Vial Monitor: 
Type 30
Secondary Packaging: 
Carton of 48 single dose vial (48 doses)[Dimensions: 4.5 x 10.8 x 14.5 cm]
Tertiary Packaging: 
Box containing 32 cartons of 48 vials (1536 doses)[Dimensions: 42 x 52 x 65 cm]

Cold Chain Volume

cm3/dose (in secondary packaging)

14.7

Preservative:

2-phenoxyethanol
with concentration: 
5 mg
Handling of opened multi-dose vials: 
Not Applicable.
Other presentations for this vaccine: 
PresentationNo. of Doses
TYPHIBEV®Vial5

Attachments

pq_360_361_Typhoid_BE_PI-2020.pdf
General
pq_360_361_ TCV_BioE_VPSAR-2022 .pdf
VPSAR (Vaccine Public Summary Assessment Report)